+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Head And Neck Cancer Drug"

Head and Neck Cancer Therapeutics Global Market Report 2024 - Product Thumbnail Image

Head and Neck Cancer Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Head and Neck Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Head and Neck Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 230 Pages
  • Global
From
From
Global Head and Neck Cancer Treatment Market 2023-2027 - Product Thumbnail Image

Global Head and Neck Cancer Treatment Market 2023-2027

  • Report
  • July 2023
  • 159 Pages
  • Global
From
From
Recurrent or Metastatic Head and Neck cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Recurrent or Metastatic Head and Neck cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Metastatic Head and Neck Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Head and Neck Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
Head and Neck Cancer Therapeutics: Global Markets - Product Thumbnail Image

Head and Neck Cancer Therapeutics: Global Markets

  • Report
  • August 2022
  • 148 Pages
  • Global
From
Global Oncolytic Virus Therapy Market Outlook to 2035 - Product Thumbnail Image

Global Oncolytic Virus Therapy Market Outlook to 2035

  • Report
  • April 2023
  • 144 Pages
  • Global
From
Loading Indicator

The Head and Neck Cancer Drug market is a subset of the larger Oncology Drugs market. It includes drugs used to treat cancers of the head and neck, such as squamous cell carcinoma, salivary gland cancer, and nasopharyngeal cancer. These drugs are typically used in combination with radiation therapy and/or surgery to treat the cancer. Common drugs used in this market include chemotherapy, targeted therapy, immunotherapy, and monoclonal antibodies. The Head and Neck Cancer Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in this market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Roche. Other companies include Novartis, Eli Lilly, and GlaxoSmithKline. Show Less Read more